Fount of Information

Acro Biosystems社 Fc receptor: the potential target proteins

この製品に関するご意見・ご照会・お問合せはこちら

COVID-19_R&D_A_YEAR_IN_REVIEW_1.png

 

Products

 

Support

 

Events

 

COVID-19 R&D

 

About Us

Fc receptor: the potential target proteins

Fc receptors play a key role in immune cell activation through antibody stimulation, they can specifically bind to the Fc region of the immunoglobulins. In addition, FcR has become a key participant in the pathogenesis of several important autoimmune diseases. Targeting Fc receptors as a therapeutic method for the treatment of inflammatory diseases and cancers. For example, blocking/neutralizing activated receptors (Antibody), Inhibitory FcγRIIB (agonist) participation. Therefore, high-quality Fc receptors are indispensable.

ACROBiosystems has launched the FcR proteins with the SUMO fusion tag and HAS fusion tag, which can be used in immunization and antibody screening to accelerating the development of specific antibody drugs.

Product list

Module

Cat. No

Product description

Fc gamma RIIIA/ CD16a

Human Fc gamma RIIIA / CD16a (V176) Protein, SUMO,His Tag

Fc gamma RIIIA/ CD16a

Human Fc gamma RIIIA / CD16a (V176) Protein, SUMO,His Tag

Fc gamma RIIB/ CD32b

Human Fc gamma  RIIB / CD32b Protein, SUMO,His Tag

Fc gamma RIIB / CD32b

Human Fc gamma  RIIB / CD32b Protein, HSA,His Tag

>>> 50+ featured Fc Receptors with SPR&BLI protocol offered

50_featured_Fc_Receptors_with_SPR_and_BLI_protocol_offered.png

Assay Data

SPR

SPR_CDA-H82E6.jpg

Biotinylated Human CD32a (H167), Avitag,His Tag (SPR & BLI verified) (Cat. No. CDA-H82E6) captured on Biotin CAP- Series S Sensor Chip can bind Rituximab with an affinity constant of 0.66 μM as determined in a SPR assay (Biacore T200).

BLIBLI_CDB-H52S9.png

Loaded Human Fc gamma RIIB / CD32b Protein, HSA,His Tag (MALS verified) (Cat. No. CDB-H52S9) on HIS1K Biosensor, can bind Rituximab with an affinity constant of 2.9 μM as determined in BLI assay (ForteBio Octet Red96e)

With a strong team of scientists, ACROBiosystems also provides high-quality integrated SPR&BLI analytical services. ACRO has served and collaborated with more than 100 customers from academia and industry. Our work supported multiple antibody drugs IND applications. 

 

>>> Click to learn more about the SPR/BLI analytical service.

Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。